In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Estee Lauder's new chairman will be Leonard Lauder as company goes public.

This article was originally published in The Rose Sheet

Executive Summary

ESTEE LAUDER FY 1995 U.S. SALES RISE 10.4% TO $1.54 BIL., according to the preliminary prospectus for an initial public offering filed by Estee Lauder on Sept. 21. Worldwide Estee Lauder sales advanced 12.5% to $2.9 bil. for the 12-month period ended June 30, 1995. Skin care sales represent 41.9% ($1.22 bil.) of worldwide sales. Makeup constitutes 34.6% of consolidated sales while fragrances generate 23.5% of sales. Estee Lauder hopes to raise $335 mil. from the stock offering.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS002040

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel